Pelvic pain and early IUD discontinuation: a prospective cohort study

Sharon R. Gerber, Noah Nattell, Nora Doty, Xiaoyu Liu, Jessica R. Overbey, Rachel Masch


Background: The aim of the study is to assess if pelvic pain is a risk factor for intrauterine device (IUD) discontinuation within one year of placement.

Methods: This is a prospective cohort study of women who had IUDs inserted at a family planning office for the primary intent of contraception. Baseline pelvic pain characteristics were assessed using a validated pelvic pain questionnaire.  Women were contacted at 1 year to assess IUD continuation.

Results: From February 1, 2014 to August 11, 2015 authors enrolled a sample of 179 women.  Of the 179 enrolled,163 participants completed the questionnaire, 98 reported a history of baseline pelvic pain and 65 reported no history of baseline pelvic pain. 20 participants were lost to follow-up. 86 women in the pelvic pain and 57 in the no pelvic pain group were included in the final analysis. Discontinuation rates at one year follow up were 25.6% (22) and 35.1% (20) respectively. There was no significant difference in those with and without pelvic pain discontinuing IUDs at one year (p = 0.22).

Conclusions: Baseline generalized pelvic pain may not be a risk factor for IUD discontinuation within one year of placement.


Intrauterine device (IUD), Pelvic pain, Risk factor

Full Text:



McNicholas C, Tessa M, Secura G, Peipert JF. The contraceptive CHOICE project round up: what we did and what we learned. Clinic Obstet Gynecol. 2014;57(4):635.

Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol. 2012;120(6):1298.

Grunloh DS, Casner T, Secura GM, Peipert JF, Madden T. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. 2013;122(6):1214-21.

Maguire K, Joslin-Roher S, Westhoff CL, Davis AR. IUDs at 1 year: predictors of early discontinuation. Contracep. 2015;92(6):575-7.

Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH, et al. The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract. 2001;51(468):541-7.

Latthe P, Latthe M, Say L, Gülmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006;6(1):177.

Eisenberg D, McNicholas C, Peipert JF. Cost as a barrier to long-acting reversible contraceptive (LARC) use in adolescents. J Adolescent Health. 2013;52(4):S59-63.

Imai A, Matsunami K, Takagi H, Ichigo S. Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review. Clinic Experiment Obstet Gynecol. 2014;41(5):495-8.

Rafique S, Decherney AH. Medical Management of Endometriosis. Clinic Obstet Gynecol. 2017;60(3):485-96.

Radzinsky VE, Khamoshina MB, Nosenko EN, Dukhin AO, Sojunov MA, Orazmuradov AA, Lebedeva MG, Orazov MR. Treatment strategies for pelvic pain associated with adenomyosis. Gynecol Endocrinol. 2016;32(2):19-22.

Hall AM, Kutler BA. Intrauterine contraception in nulliparous women: a prospective survey. J Fam Plann Reprod Health Care. 2016 ;42(1):36-42.

Bateson D, Harvey C, Trinh L, Stewart M, Black KI. User characteristics, experiences and continuation rates of copper intrauterine device use in a cohort of Australian women. Aus New Zealand J Obstet Gynaecol. 2016;56(6):655-61.